107 related articles for article (PubMed ID: 7554288)
21. [Alcohol catabolism in liver diseases].
Lelbach WK
Dtsch Med Wochenschr; 1969 May; 94(21):1136-7. PubMed ID: 5769159
[No Abstract] [Full Text] [Related]
22. [Factors stimulating liver regeneration; role of anabolic steroids in reactive regeneration in chronic liver diseases].
Nicolaescu T; Bordeianu A; Bittman E; Gabrielescu E; Stoiculescu P; Drăgulescu N
Rev Roum Physiol; 1969; 6(2):119-26. PubMed ID: 5821595
[No Abstract] [Full Text] [Related]
23. [Prescription of drugs in liver diseases].
Held H
Internist (Berl); 1980 Dec; 21(12):724-34. PubMed ID: 7009474
[No Abstract] [Full Text] [Related]
24. [Benzodiazepines and liver diseases. Pharmacokinetics and pharmacodynamic effects].
Antoni M; Botta-Fridlund D; Bourlière M; Bun H; Gauthier AP
Gastroenterol Clin Biol; 1990; 14(5):492-500. PubMed ID: 1973130
[No Abstract] [Full Text] [Related]
25. Drug disposition in liver disease.
Shand DG
N Engl J Med; 1977 Jun; 296(26):1527-8. PubMed ID: 865536
[No Abstract] [Full Text] [Related]
26. [Liver diseases and abnormal sugar metabolism].
Ohnishi K; Okuda K
Nihon Rinsho; 1982 Feb; 40(2):415-21. PubMed ID: 7045460
[No Abstract] [Full Text] [Related]
27. [Determination of zinc content in blood, liver tissue, urine and hair of patients with chronic liver diseases and its clinical significance].
Dang ZD
Zhonghua Nei Ke Za Zhi; 1983 Dec; 22(12):758-60. PubMed ID: 6675940
[No Abstract] [Full Text] [Related]
28. [Studies on vitamin B12 resorption in chronic liver diseases].
Konrad H; Teichmann W; Kiencke H; Bielka B; Claus R
Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):179-83. PubMed ID: 4792418
[No Abstract] [Full Text] [Related]
29. Drug disposition in liver disease.
Fruncillo RJ
Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
[No Abstract] [Full Text] [Related]
30. Heptaic collagen and non-collagen protein synthesis in man with and without liver disease.
Hirayama C; Kimura N; Irisa T; Masuya T
Clin Chim Acta; 1968 Jul; 21(1):49-54. PubMed ID: 5658955
[No Abstract] [Full Text] [Related]
31. [Azathioprine pharmacokinetics in animal experiment and in patients with chronic liver diseases].
Bär U; Becker H; May B; Mayer D; Ohlendorf S; Otto P; Schmidt FW
Verh Dtsch Ges Inn Med; 1973; 79():943-6. PubMed ID: 4790049
[No Abstract] [Full Text] [Related]
32. Hepatic fibrosis.
Rojkind M; Kershenobich D
Clin Gastroenterol; 1981 Sep; 10(3):737-54. PubMed ID: 6274551
[No Abstract] [Full Text] [Related]
33. [Studies on the excretory liver function using 24- 14 C-cholic acid].
Klapdor R
Acta Hepatogastroenterol (Stuttg); 1972 Feb; 19(1):53-66. PubMed ID: 4664356
[No Abstract] [Full Text] [Related]
34. [Different elimination velocity of indocyanine green in liver diseases of various severity].
Brügmann E
Z Gesamte Inn Med; 1973 Sep; 28(17):523-6. PubMed ID: 4767186
[No Abstract] [Full Text] [Related]
35. [Dangerous drugs in hepatic insufficiency].
Isal JP; Caulin C
Med Chir Dig; 1979; 8(5):447-9. PubMed ID: 534025
[No Abstract] [Full Text] [Related]
36. [Aspects of cortisol metabolism in liver diseases].
Della Casa L; Boni M
Endocrinol Sci Cost; 1967 Nov; 29(5):344-53. PubMed ID: 5616116
[No Abstract] [Full Text] [Related]
37. [Hydroxyproline excretion in children with chronic liver diseases].
Zhivitsa LV; Safonova ES
Vopr Okhr Materin Det; 1976 May; 21(5):64-7. PubMed ID: 1027285
[No Abstract] [Full Text] [Related]
38. [Side effects of drugs--predictable hazards for patients with liver disease].
Baumgarten R
Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279
[No Abstract] [Full Text] [Related]
39. Metabolism of (131-I)gamma globulins in patients with chronic liver disease.
Hirayama C; Fukuda T; Toda T
Clin Chim Acta; 1970 Mar; 27(3):409-13. PubMed ID: 4190908
[No Abstract] [Full Text] [Related]
40. alpha-1-Antitrypsin in Indian childhood cirrhosis.
Mehendiratta VK; Dhatt PS; Singh H; Mehta HC
Indian Pediatr; 1986 Apr; 23(4):311-2. PubMed ID: 3488960
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
